• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jan 19, 2018
Clinical News

Albireo gets $55M for elobixibat approval in Japan

Read More
BioCentury | Feb 8, 2017
Clinical News

Elobixibat regulatory update

Read More
BioCentury | Oct 10, 2016
Clinical News

Elobixibat: Phase III data

Read More
BioCentury | Oct 3, 2016
Clinical News

Albireo's elobixibat meets in Japanese Phase III study

Read More
BioCentury | Nov 23, 2015
Clinical News

Elobixibat: Phase III started

Read More
BioCentury | Jun 20, 2013
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Read More
BioCentury | May 13, 2013
Clinical News

Elobixibat: Phase III started

Read More
BioCentury | Apr 9, 2012
Company News

Albireo, Ajinomoto deal

Read More
BioCentury | Apr 4, 2012
Company News

Ajinomoto, Albireo partner in Asia for elobixibat

Read More
BioCentury | May 23, 2011
Clinical News

A3309: Phase IIb data

Read More
Items per page:
1 - 10 of 17